NCT05320757 2025-06-11
Effects of PARP Inhibitor on Tumor Microenvironment in High-risk Endometrial Cancer Patients
The University of Hong Kong
Phase EARLY_PHASE1 Completed
Clinical Trials
8 trialsNCT02728830 2024-02-21
A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers
Duke University
Phase EARLY_PHASE1 Completed
NCT01979003 2022-02-24
Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion
University of Arkansas
Phase EARLY_PHASE1 Completed
NCT02767362 2020-07-07
A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium
UNC Lineberger Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT01705288 2020-02-17
Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
Masonic Cancer Center, University of Minnesota
Phase EARLY_PHASE1 Completed
NCT02646319 2019-06-06
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT01205672 2017-06-02
Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT01911247 2013-07-30
Preoperative Window Study of Metformin for the Treatment of Endometrial Cancer
UNC Lineberger Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed